Original Articles
Copyright ©The Author(s) 1998. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Apr 15, 1998; 4(2): 133-136
Published online Apr 15, 1998. doi: 10.3748/wjg.v4.i2.133
Stage II surgical resection of hepatocellular carcinoma after TAE: a report of 38 cases
Jian-Hua Wang, Gui Lin, Zhi-Ping Yan, Xiao-Lin Wang, Jie-Ming Cheng, Mao-Quan Li
Jian-Hua Wang, Gui Lin, Zhi-Ping Yan, Xiao-Lin Wang, Jie-Ming Cheng, Mao-Quan Li, Department of Radiology, Zhongshan Hospital of Shanghai Medical University, Shanghai 200032, China
Jian-Hua Wang, male, born on 1953-01-07 in Huainan City, Anhui Province, Han nationality, graduated from the Graduate School of Shanghai Medical University as M.D. in 1989, professor of radiology, majoring interventional radiology, having 23 papers published. Presented at the 1st Asian-Pacific Congress of Cardivascular & Interventional Radiology, Seoul, 24-27 May, 1993
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Jian-Hua Wang, Department of Radiology, Zhongshan Hospital of Shanghai Medical University, Shanghai 200032, China
Telephone: +86·21·64041990 ext 2832 Fax: +86·21·64038472
Received: September 2, 1997
Revised: December 20, 1997
Accepted: February 20, 1998
Published online: April 15, 1998
Abstract

AIM: To evaluate the curative effect of stage II surgical resection of hepatocellular carcinoma after TAE.

METHODS: Thirty-eight patients with unresectable hepatocellular carcinoma were treated by transcatheter arterial embolization (TAE). When the sizes of tumors were markedly reduced after TAE, stage II surgical resections were performed.

RESULTS: Before TAE, the diameters of tumors were 12.84 cm ± 4.87 cm (x ± s), but reduced to 5.12 cm ± 1.82 cm (x ± s) after TAE (P < 0.001). Pathologic examination of the resected specimens revealed obvious necrosis in most cases. After surgery, 26 patients were alive, with the longest survival of 96 months, twelve died and 10 had tumor recurrence.

CONCLUSION: Patients in moderate and advanced stages of hepatocellular carcinoma after TAE should be treated surgically, but the indication must be controlled strictly.

Keywords: carcinoma, hepatocellular/therapy; liver neoplasm/therapy; carcinoma, hepatocellular/surgery; liver neoplasms/surgery; embolization, therapeutic; hepatectomy